Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from BRIEF COMMUNICATION

  • Measuring Total Metabolic Tumor Volume from <sup>18</sup>F-FDG PET: A Reality Check
    You have access
    Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check
    Ronald Boellaard, Gerben J.C. Zwezerijnen, Irène Buvat, Laurence Champion, Narinée Hovhannisyan-Baghdasarian, Fanny Orlhac, Anne I.J. Arens, Daphne Lobeek, Filiz Celik, Cristina Mitea, Julia E. Huijbregts, Nelleke Tolboom, Bart de Keizer, Roelf Valkema, Floris H.P. van Velden, Petra Dibbets-Schneider, Sanne E. Wiegers, Pieternella J. Lugtenburg, Sally F. Barrington and Josée M. Zijlstra
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 802-805; DOI: https://doi.org/10.2967/jnumed.124.269271
  • Bioanalytic Hybrid System Merging 3-Dimensional Cell Culture and Chromatographic Precision for Unprecedented Preclinical Insights in Molecular Imaging
    Open Access
    Bioanalytic Hybrid System Merging 3-Dimensional Cell Culture and Chromatographic Precision for Unprecedented Preclinical Insights in Molecular Imaging
    Verena Pichler, Verena Schwingenschlögl-Maisetschläger, Irem Duman, Xavier Monforte, Stefanie Ponti, Lukas Zimmermann, Elma Joldic, Monika Dumanic, Chrysoula Vraka, Marcus Hacker, Christian Kraule and Andreas Herbert Teuschl-Woller
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 813-816; DOI: https://doi.org/10.2967/jnumed.124.269133
  • Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
    You have access
    Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
    Edwin C. Pratt, Travis M. Shaffer, David Bauer, Jason S. Lewis and Jan Grimm
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 817-821; DOI: https://doi.org/10.2967/jnumed.124.268806
  • First-in-Human Serum Stability Studies of [<sup>177</sup>Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy
    Open Access
    First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy
    Veronika Felber, Nadine Holzleitner, Markus Joksch, Tim Suhrbier, Gunhild von Amsberg, Sarah Schwarzenböck, Jens Kurth, Martin Heuschkel, Thomas Günther and Bernd J. Krause
    Journal of Nuclear Medicine April 30, 2025, jnumed.124.269132; DOI: https://doi.org/10.2967/jnumed.124.269132
  • Initial Experience with Dual-Time-Point [<sup>18</sup>F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism
    You have access
    Initial Experience with Dual-Time-Point [18F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism
    Thorsten Derlin, Dennis Kleine-Döpke, Lavinia Neubert, Tobias L. Ross, Bastian P. Ringe, Moritz Schmelzle and Frank M. Bengel
    Journal of Nuclear Medicine April 24, 2025, jnumed.124.269387; DOI: https://doi.org/10.2967/jnumed.124.269387
  • Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT
    You have access
    Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT
    Mateus de Oliveira Taveira, Ali Aria Razmaria, Heiko Schoder and Randy Yeh
    Journal of Nuclear Medicine April 10, 2025, jnumed.124.269361; DOI: https://doi.org/10.2967/jnumed.124.269361
  • Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX–Based Attenuation Correction Using a Long–Axial-Field-of-View PET/CT Scanner
    You have access
    Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX–Based Attenuation Correction Using a Long–Axial-Field-of-View PET/CT Scanner
    Hasan Sari, Mohammadreza Teimoorisichani, Marco Viscione, Clemens Mingels, Robert Seifert, Kuangyu Shi, Michael Morris, Eliot Siegel, Babak Saboury, Thomas Pyka and Axel Rominger
    Journal of Nuclear Medicine April 10, 2025, jnumed.124.268380; DOI: https://doi.org/10.2967/jnumed.124.268380
  • Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET
    You have access
    Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET
    Suzanne van der Gaag, André N. Vis, Imke H. Bartelink, Josephina C.C. Koppes, Marina Hodolic, Harry Hendrikse and Daniela E. Oprea-Lager
    Journal of Nuclear Medicine March 1, 2025, 66 (3) 373-376; DOI: https://doi.org/10.2967/jnumed.124.268340
  • Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical Therapy
    Open Access
    Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical Therapy
    Johanna S. Enke, Nic G. Reitsam, Sebastian Dintner, Friederike Liesche-Starnecker, Tina Schaller, Josua A. Decker, Angela Langer, Eva Sipos, Ana Antic Nikolic, Thomas Kröncke, Martin Trepel, Constantin Lapa, Rainer Claus, Bruno Märkl and Ralph A. Bundschuh
    Journal of Nuclear Medicine February 1, 2025, 66 (2) 245-249; DOI: https://doi.org/10.2967/jnumed.124.268513
  • PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort
    You have access
    PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort
    Luca Ceriani, Lisa Milan, Maria Cristina Pirosa, Maurizio Martelli, Teresa Ruberto, Luciano Cascione, Peter W.M. Johnson, Andrew J. Davies, Giovannino Ciccone and Emanuele Zucca
    Journal of Nuclear Medicine February 1, 2025, 66 (2) 209-214; DOI: https://doi.org/10.2967/jnumed.124.268874

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
SNMMI

© 2025 SNMMI

Powered by HighWire